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NMR sample preparation and spectra acquisition
Frozen serum samples were thawed at room temperature and 300 μl of each sample were added to a total of 300 μl of a sodium phosphate buffer at pH 7.4 (75 mM Na2HPO4, 20 % (v/v) D2O, 0.025 % (v/v) NaN3 and 0.8 % (w/v) sodium trimethylsilyl[2,2,3,3-2 2 H4]propionate (TMSP)). From the mixture, 450 μl were transferred into a 4.25 mm NMR disposable tube, acquired from Bruker BioSpin srl.
1 H-NMR experiments were conducted using a Bruker 600 MHz metabolic profiler (Bruker BioSpin) operating at 600.13 MHz proton Larmor frequency and equipped with a 5 mm CPTCI 1 H-13 C-31 P and 2 H-decoupling cryoprobe including a z-axis gradient coil, an automatic tuning-matching and an automatic sample changer. A BTO 2000 thermocouple served for temperature stabilization at the level of approximately 0.1 K at the sample. Before measurement, samples were kept for at least 3 min inside the NMR probehead for temperature equilibration (310 K). Three mono-dimensional (1D) spectra were acquired: a) A standard Nuclear Overhauser Effect Spectroscopy (NOESY) (1) 1D presat pulse sequence (noesygppr1d.comp, Bruker BioSpin) with 98304 data points, 18028 Hz spectral width, acquisition time of 2.7 s, relaxation delay of 4 s and mixing time of 0.1 s. NOESY spectra contain 1 H-NMR signals from small molecular weight metabolites as well as from high molecular weight molecules, such as lipids and lipoproteins. b) A standard Carr-Purcell-Meiboom-Gill (CPMG) (2) pulse sequence (cpmgpr1d.comp, Bruker BioSpin) with 73728 data points, spectral width of 12019 Hz and relaxation delay of 4 s. In this NMR experiment, 1 H-NMR signals of very large macromolecules are filtered out, resulting in the clearer observation of 1 H-NMR signals from small molecular weight metabolites than in NOESY spectra. c) A standard DIFFUSION-EDITED (3) pulse sequence (ledbgppr2s1d.comp; Bruker BioSpin) with 98304 data points, spectral width of 18028 Hz and relaxation delay of 4 s. In this experiment, mostly 1 H-NMR signals from large molecules are observed. For all NMR spectra 64 scans were acquired. Each one of the experiments is performed within < 5 min.
NMR acquisition free induction decays (FIDs) were multiplied by an exponential function equivalent to 1.0 Hz line-broadening factor before applying Fourier transform, and all transformed spectra were automatically corrected for phase and baseline distortions. Moreover, NOESY and CPMG spectra were calibrated by setting the glucose doublet at 5.24 ppm (this is preferred with respect to setting the TMSP singlet at 0 ppm due to TMSP interaction with serum albumin). By the use of AMIX software (Bruker Biospin), each spectrum was divided into 0.02 ppm chemical shift bins ranging from 0.3 to 9.0 ppm, and the 4.4 to 5.0 ppm spectral region around the suppressed water 1 H-NMR signal was excluded. Total area normalization was applied upon the remaining spectral buckets. The score plot has been constructed after the OPLS-DA analysis of the serum spectra and the 3 first latent variables (LVs) components were used (the 3 rd one is the orthogonal component), which were also used for the final model production, since after 3 rd component the classification error in the model was increasing (see below Figure S5a ). Except for the three groups samples distribution, the 95 % confidence of each group is depicted. . 2D Score plot of the OPLS-DA classification of symptomatic gallstones, cholecystitis and pancreatitis diseases based upon the 1 H-NMR diffusion patients' serum spectra. 2 first latent variables (LVs) components were used, which were also used for the final model production, since after 2 nd component the classification error in the model were increasing (see below Figure S15 ). Table S4 . Prediction probabilities of test data by the use of the NOESY and CPMG models, for the symptomatic gallstones, cholecystitis and pancreatitis diseases. Samples with red font are erroneously predicted, and the bold highlighted values correspond to the prediction probabilities of test data for the disease that should be assigned according to medical doctors' diagnosis.
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